Condition: Trauma · Hemorrhage · Sponsor: Jason Sperry
The CAlcium and VAsopressin following Injury Early Resuscitation (CAVALIER) Trial is a proposed 4 year, double-blind, mutli-center, prehospital and early in hospital phase randomized trial designed to determine the efficacy and safety of prehospital calcium and early in hospital vasopressin in patients at risk of hemorrhagic shock.
This description comes directly from the study's public registry record.
Jason Sperry, MD · 4128028270 · sperryjl@upmc.edu
Always discuss trial participation with your own doctor first.
| University of Arizona | Tucson, Arizona, United States | Recruiting |
| University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | Recruiting |
| Zuckerberg San Francisco General Hospital and Trauma Center at University of California, San Francisco | San Francisco, California, United States | Recruiting |
| Denver Health Medical Center | Denver, Colorado, United States | Recruiting |
| University of Miami | Miami, Florida, United States | Recruiting |
| University of Maryland, Baltimore | Baltimore, Maryland, United States | Recruiting |
| Hennepin County Medical Center | Minneapolis, Minnesota, United States | Recruiting |
| University of Missouri Health Care | Columbia, Missouri, United States | Recruiting |
| University of New Mexico | Albuquerque, New Mexico, United States | Recruiting |
| The Ohio State University Wexner Medical Center | Columbus, Ohio, United States | Recruiting |
| Mount Carmel East Hospital | Columbus, Ohio, United States | Recruiting |
| Allegheny Health Network | Pittsburgh, Pennsylvania, United States | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05958342